NB3 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Neurocrine Biosciences Inc

Watchlist Manager

Watchlist

Price: 115.25 EUR 0.79%

Market Cap: €6.5B

N	Neurocrine Biosciences Inc SWB:NB3	US
	Booz Allen Hamilton Holding Corp NYSE:BAH	US
A	Argan Inc F:1AW	US
E	Empresas CMPC SA SGO:CMPC	CL
G	Go Digit General Insurance Ltd NSE:GODIGIT	IN
T	TX Group AG XBER:TAMN	CH
	Daimler Truck Holding AG LSE:0AB9	DE
E	Exail Technologies SWB:2G3	FR
A	Aptargroup Inc F:AGT	US
	Ironman International Ltd XTSX:IMI	CA
	Deutsche Lufthansa AG F:LHA	DE
B	Barclays PLC DUS:BCY	UK

Profitability Summary

Neurocrine Biosciences Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

98%

Strong 3Y Average Gross Margin

98%

Gross Margin is Increasing

98% > 98%

Healthy Operating Margin

26%

Sustainable 3Y Average Operating Margin

22%

Operating Margin is Increasing

18% > 26%

Healthy Net Margin

22%

Sustainable 3Y Average Net Margin

15%

Net Margin is Increasing

11% > 22%

Exceptional Free Cash Flow Margin

27%

Strong 3Y Average Free Cash Flow Margin

23%

Free Cash Flow Margin is Increasing

17% > 27%

Positive ROE

23%

Positive 3Y Average ROE

Positive 3Y Average ROIC

22%

ROIC is Increasing

19% > 20%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.